In a mouse model, a single dose of ATL-201 durably suppressed seizures and improved behavior through six months, according to the firm.

Atalanta Therapeutics, a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases, today announced the publication of preclinical data in the journal ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

EMA orphan drug designation is awarded to drugs intended to treat rare diseases that are life-threatening or chronically debilitatingPreeclampsia, a serious obstetric complication, is a leading cause ...

Patients at risk for heart disease experienced significant reductions in apolipoprotein B and LDL cholesterol levels on ...

RNA therapeutics market is expanding, driven by advancements in gene therapy, personalized medicine, and RNA-based drug delivery, along with rising research in mRNA vaccines, antisense ...

Founded in 1980, Sarepta Therapeutics (NASDAQ:SRPT) is a biopharmaceutical company focused on developing precision genetic ...

As antibody-drug conjugates (ADCs) advance in precision oncology, diagnostics play a vital role in identifying eligible patients, validating biomarkers and supporting regulatory approval. A ...

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.

First-ever positive profit, entering a new era of growth and global innovation SAN FRANSISCO and SUZHOU, China, March 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: ...

WASHINGTON, March 20 (Reuters) - The U.S. State Department has approved what would be the first sale of advanced precision kill weapon systems to Saudi Arabia for an estimated cost of $100 million ...